Knowledgebase

Electromagnetic hypersensitivity

EMR Australia - Friday, January 29, 2016

Recent studies shed new insights on the condition of electromagnetic hypersensitivity (EHS).

Diagnosis and treatment

A group of 17 scientists from six nations has produced the EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses’. 1

Their paper reports the results of Professor Belpomme’s study on 1200 people with EHS and/or multiple chemical sensitivity (MCS). ‘Both EHS and MCS appear to paint a common picture of inflammation-related hyper-histaminemia, oxidative stress, autoimmune response and BBB [blood-brain-barrier] opening, and a deficit in melatonin excretion.’

As a first step, the authors recommend that sufferers measure fields at home and work and take action to reduce their exposure.

The authors also recommend a number of diagnostic tests as well as treatments, including oxidation, treating intestinal problems, improving nutrition, detoxification, improving mitochondrial function, reducing inflammation, sauna, exposure to natural light, oxygen therapy, exercise, drinking good quality water and appropriate dental care.

EHS perspective

The Swedish government classifies EHS as a ‘functional impairment’ - that is, a difficulty that limits the sufferer’s ability to engage in certain essential activities of life.2 This means that sufferers are not ‘seen as patients but citizens reacting to an inferior environment,’ said author, Professor Olle Johansson of Karolinska Institute. As a result of this approach, sufferers are not subjected to a battery of diagnostic tests and are not prescribed psychiatric treatments—as is recommended in many countries, including Australia.

The Swedish approach to EHS also enables sufferers to obtain economic support and legal protection.

In his paper, Professor Johansson describes the results of his research which showed that EHS people exposed to electromagnetic radiation had skin damage consistent with other forms of radiation exposure. Specifically, he found changes in the numbers and behaviours of mast cells, which are involved in pain, itching, edema and erythema— symptoms that are reported by many EHS sufferers.

EHS is not a nocebo effect

No, electromagnetic hypersensitivity is not a psychological (nocebo) effect, says M Dieudonné from France. After interviewing 40 people claiming to have EHS, Dr Dieudonné determined that symptoms appeared before people began questioning the effects of electromagnetic fields on their health—and not as a result of their negative perceptions about technology.

1. Belyaev, I et al, ‘EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses,’ Rev Environ Health, 30 (4):337-71, 2015.

2. Johansson, O, ‘Electrohypersensitivity: a functional impairment due to an inaccessible environment’, Rev Environ Health, 30(4):311-21, 2015.

3. Dieudonné, M, ‘Does electromagnetic hypersensitivity originate from nocebo responses? Indications from a qualitative study’, Bioelectromagnetics 37(1), 14-24,


About The Author - Lyn McLean is a consumer advocate, author and educator and has been monitoring and writing on the subject of electromagnetic radiation (EMR) for over 20 years. She is the director of EMR Australia.


Follow on Feedly follow us in feedly


Trackback Link
http://www.emraustralia.com.au/BlogRetrieve.aspx?BlogID=419&PostID=620973&A=Trackback
Trackbacks
Post has no trackbacks.

Recent Posts

Categories

Tags

Dr. Henry Lai John Cherry T Abelin Vijayalaxmi and Maria Scarfi Dr Linda Erdreich Dr Ronald Powell Dr James Suckling Salzburg Resolution Dr Asad Rahmani Dr Lisa Nagy Grant Brecht Dr Larry Marshall John Patterson Dr Lennart Hardell Frank Drews Professor Martin Pall Dr Stephanie McCarter (MD) Dr Stephen Solomon Associate Professor Ray Kearney OAM Anne Silk Dr Kenneth Foster Dr Martin Pall Lennart Hardell Professor Belpomme WHO Dr Cornelia Waldmann-Selsam Dennis J Kucinich Dr Hugh Taylor IAFF A. Garcia Dr Igor Belyaev Dr S Mortazavi Dr Christine Aschermann Dr Siegal Sadetzki E Lopez-Martin Dr Jacquinta Lee Stewart Committee Reports Kaspersky Lab Dr De-Kun Li Cindy Sage Prof Trevor Marshall Dr Arpad Szallasi (MD) Catalyst Dr Mary Redmayne David Suzuki Dr Priyanka Bandara Mona Nilsson Professor Anthony Miller Dr Devra Davis US Senate Hearing Dr Jean Monroe Dr. Neil Cherry Dr David Carpenter Ken Karipidis Essex University Study Dr Markus Kern Professor Michael Berk Dr Lawrence Anukam Dr Don Masich Frank Clegg Specific Absorption Rate (SARs) Jim Phillips Prof Olle Johansson Venice Resolution Michael Carlberg Dr Michael Kundi Michael Dolan ARPANSA RF Standard Dr Maryanne Demasi Brett Moule Dr Louis Slesin Paul Wentworth SAM Model Professor Bruce Armstrong Dr William Rea Dr, Louis, Slesin Dr Gilbert de Paula (MD) Dr Dominique Belpomme Dr Fernando Saravi Dr Cyril Smith Dr Olga Naidenko Dr Ron Overberg Mr Gary Melik Dr. Masayuki Tatemichi Dr Christopher Portier Ohio State University Dr Magda Havas Dr Dieudonné SCENIHR Report Dr Dariuz Leszczynski Dr James Oschman Alasdair Phillips Sydney Council Phone Tower Forum Prof Andrew Marino Professor Rodney Croft Dr John Dockerty Professor Hugo Lagercrantz

Archive

SuMoTuWeThFrSa
1234567
891011121314
15161718192021
22232425262728
293031    

EMR Australia © 2017. All Rights Reserved. Terms & Conditions | Privacy | Sitemap | Adobe Business Catalyst Sydney